Allergen-induced asthma, chronic rhinosinusitis and transforming growth factor-β superfamily signaling: mechanisms and functional consequences

References

• Vos T, Abajobir AA, Abate KH, et al., GBD 2016 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the global burden of disease study 2016. Lancet. 2017;390:1211–1259.
   PubMed Web of Science ®Google Scholar
• Chung KF, Wenzel SE, Brozek JL, et al. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J. 2014;43:343–373.
   PubMed Web of Science ®Google Scholar
• Haldar P, Pavord ID, Shaw DE, et al. Cluster analysis and clinical asthma phenotypes. Am J Respir Crit Care Med. 2008;178:218–224.
   PubMed Web of Science ®Google Scholar
• Lotvall J, Akdis CA, Bacharier LB, et al. Asthma endotypes: a new approach to classification of disease entities within the asthma syndrome. J Allergy Clin Immunol. 2011;127:355–360.
   PubMed Web of Science ®Google Scholar
• Fricker M, Gibson PG. Macrophage dysfunction in the pathogenesis and treatment of asthma. Eur Respir J. 2017Sep 12;50(3). pii: 1700196.
   Web of Science ®Google Scholar
• Toussaint M, Jackson DJ, Swieboda D, et al. Host DNA released by NETosis promotes rhinovirus-induced type-2 allergic asthma exacerbation. Nat Med. 2017;23:681–691.
   PubMed Web of Science ®Google Scholar
• Ray A, Oriss TB, Wenzel SE. Emerging molecular phenotypes of asthma. Am J Physiol Lung Cell Mol Physiol. 2015;308:L130–140.
   PubMed Web of Science ®Google Scholar
• Kariyawasam HH, Aizen M, Barkans J, et al. Remodeling and airway hyperresponsiveness but not cellular inflammation persist after allergen challenge in asthma. Am J Respir Crit Care Med. 2007;175:896–904.
   PubMed Web of Science ®Google Scholar
• Kay AB, Ali FR, Heaney LG, et al. Airway expression of calcitonin gene-related peptide in T-cell peptide-induced late asthmatic reactions in atopics. Allergy. 2007;62:495–503.
   PubMed Web of Science ®Google Scholar
• Papi A, Brightling C, Pedersen SE, et al. Asthma. Lancet. 2018;391:783–800.
   PubMed Web of Science ®Google Scholar
• Coumou H, Westerhof GA, de Nijs SB, et al. Predictors of accelerated decline in lung function in adult-onset asthma. Eur Respir J. 2018;51:1701785.
   PubMed Web of Science ®Google Scholar
• de Nijs SB, Venekamp LN, Bel EH. Adult-onset asthma: is it really different? Eur Respir Rev. 2013;22:44–52.
   PubMedGoogle Scholar
• White AA, Stevenson DD. Aspirin-exacerbated respiratory disease. N Engl J Med. 2018;379:1060–1070.
   PubMed Web of Science ®Google Scholar
• Samitas K, Carter A, Kariyawasam HH, et al. Upper and lower airway remodelling mechanisms in asthma, allergic rhinitis and chronic rhinosinusitis: the one airway concept revisited. Allergy. 2018;73:993–1002.
   PubMed Web of Science ®Google Scholar
• Chang H, Brown CW, Matzuk MM. Genetic analysis of the mammalian transforming growth factor-beta superfamily. Endocr Rev. 2002;23:787–823.
   PubMed Web of Science ®Google Scholar
• Piek E, Heldin CH, Ten Dijke P. Specificity, diversity, and regulation in TGF-beta superfamily signaling. Faseb J. 1999;13:2105–2124.
   PubMed Web of Science ®Google Scholar
• Sun PD, Davies DR. The cystine-knot growth-factor superfamily. Annu Rev Biophys Biomol Struct. 1995;24:269–291.
   PubMedGoogle Scholar
• de Martin R, Haendler B, Hofer-Warbinek R, et al. Complementary DNA for human glioblastoma-derived T cell suppressor factor, a novel member of the transforming growth factor-beta gene family. Embo J. 1987;6:3673–3677.
   PubMed Web of Science ®Google Scholar
• Ten Dijke P, Geurts van Kessel AH, Foulkes JG, et al. Transforming growth factor type beta 3 maps to human chromosome 14, region q23-q24. Oncogene. 1988;3:721–724.
   PubMed Web of Science ®Google Scholar
• Lander ES, Linton LM, Birren B, et al. Initial sequencing and analysis of the human genome. Nature. 2001;409:860–921.
   PubMed Web of Science ®Google Scholar
• Assoian RK, Komoriya A, Meyers CA, et al. Transforming growth factor-beta in human platelets. Identification of a major storage site, purification, and characterization. J Biol Chem. 1983;258:7155–7160.
   PubMed Web of Science ®Google Scholar
• Kulkarni AB, Ward JM, Yaswen L, et al. Transforming growth factor-beta 1 null mice. An animal model for inflammatory disorders. Am J Pathol. 1995;146:264–275.
   PubMed Web of Science ®Google Scholar
• Sanford LP, Ormsby I, Gittenberger-de Groot AC, et al. TGFbeta2 knockout mice have multiple developmental defects that are non-overlapping with other TGFbeta knockout phenotypes. Development. 1997;124:2659–2670.
   PubMed Web of Science ®Google Scholar
• Kaartinen V, Voncken JW, Shuler C, et al. Abnormal lung development and cleft palate in mice lacking TGF-beta 3 indicates defects of epithelial-mesenchymal interaction. Nat Genet. 1995;11:415–421.
   PubMed Web of Science ®Google Scholar
• Fynan TM, Reiss M. Resistance to inhibition of cell growth by transforming growth factor-beta and its role in oncogenesis. Crit Rev Oncog. 1993;4:493–540.
   PubMed Web of Science ®Google Scholar
• Vale W, Rivier J, Vaughan J, et al. Purification and characterization of an FSH releasing protein from porcine ovarian follicular fluid. Nature. 1986;321:776–779.
   PubMed Web of Science ®Google Scholar
• Bloise E, Ciarmela P, Dela Cruz C, et al. Activin A in mammalian physiology. Physiol Rev. 2019;99:739–780.
   PubMed Web of Science ®Google Scholar
• Kariyawasam HH, Semitekolou M, Robinson DS, et al. Activin-A: a novel critical regulator of allergic asthma. Clin Exp Allergy. 2011;41(11):1505–1514.
   PubMed Web of Science ®Google Scholar
• Hogan BL. Bone morphogenetic proteins in development. Curr Opin Genet Dev. 1996;6:432–438.
   PubMed Web of Science ®Google Scholar
• Wang EA, Rosen V, Cordes P, et al. Purification and characterization of other distinct bone-inducing factors. Proc Natl Acad Sci U S A. 1988;85:9484–9488.
   PubMed Web of Science ®Google Scholar
• Wu DH, Hatzopoulos AK. Bone morphogenetic protein signaling in inflammation. Exp Biol Med (Maywood). 2019;244:147–156.
   PubMed Web of Science ®Google Scholar
• Kocwin M, Jonakowski M, Przemecka M, et al. Selected bone morphogenetic proteins - the possibility of their use in the diagnostics and therapy of severe asthma. Adv Respir Med. 2017;85:109–115.
   PubMed Web of Science ®Google Scholar
• Van Obberghen-Schilling E, Roche NS, Flanders KC, et al. Transforming growth factor beta 1 positively regulates its own expression in normal and transformed cells. J Biol Chem. 1988;263:7741–7746.
   PubMed Web of Science ®Google Scholar
• Jenkins G. The role of proteases in transforming growth factor-beta activation. Int J Biochem Cell Biol. 2008;40:1068–1078.
   PubMed Web of Science ®Google Scholar
• Schultz-Cherry S, Chen H, Mosher DF, et al. Regulation of transforming growth factor-beta activation by discrete sequences of thrombospondin 1. J Biol Chem. 1995;270:7304–7310.
   PubMed Web of Science ®Google Scholar
• Araya J, Cambier S, Morris A, et al. Integrin-mediated transforming growth factor-beta activation regulates homeostasis of the pulmonary epithelial-mesenchymal trophic unit. Am J Pathol. 2006;169:405–415.
   PubMed Web of Science ®Google Scholar
• Munger JS, Huang X, Kawakatsu H, et al. The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis. Cell. 1999;96:319–328.
   PubMed Web of Science ®Google Scholar
• Antenos M, Zhu J, Jetly NM, et al. An activin/furin regulatory loop modulates the processing and secretion of inhibin alpha- and betaB-subunit dimers in pituitary gonadotrope cells. J Biol Chem. 2008;283:33059–33068.
   PubMed Web of Science ®Google Scholar
• Altmann CR, Chang C, Munoz-Sanjuan I, et al. The latent-TGFbeta-binding-protein-1 (LTBP-1) is expressed in the organizer and regulates nodal and activin signaling. Dev Biol. 2002;248:118–127.
   PubMed Web of Science ®Google Scholar
• Shi Y, Massague J. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell. 2003;113:685–700.
   PubMed Web of Science ®Google Scholar
• Olsen OE, Wader KF, Hella H, et al. Activin A inhibits BMP-signaling by binding ACVR2A and ACVR2B. Cell Commun Signal. 2015;13:27.
   PubMed Web of Science ®Google Scholar
• Aoki H, Fujii M, Imamura T, et al. Synergistic effects of different bone morphogenetic protein type I receptors on alkaline phosphatase induction. J Cell Sci. 2001;114:1483–1489.
   PubMed Web of Science ®Google Scholar
• Roelen BA, van Rooijen MA, Mummery CL. Expression of ALK-1, a type 1 serine/threonine kinase receptor, coincides with sites of vasculogenesis and angiogenesis in early mouse development. Dev Dyn. 1997;209:418–430.
   PubMed Web of Science ®Google Scholar
• Matsuzaki K. Smad phospho-isoforms direct context-dependent TGF-beta signaling. Cytokine Growth Factor Rev. 2013;24:385–399.
   PubMed Web of Science ®Google Scholar
• Zhang YE. Non-Smad pathways in TGF-beta signaling. Cell Res. 2009;19:128–139.
   PubMed Web of Science ®Google Scholar
• Nakao A, Afrakhte M, Moren A, et al. Identification of Smad7, a TGFbeta-inducible antagonist of TGF-beta signalling. Nature. 1997;389:631–635.
   PubMed Web of Science ®Google Scholar
• Afrakhte M, Moren A, Jossan S, et al. Induction of inhibitory Smad6 and Smad7 mRNA by TGF-beta family members. Biochem Biophys Res Commun. 1998;249:505–511.
   PubMed Web of Science ®Google Scholar
• Hashimoto O, Nakamura T, Shoji H, et al. A novel role of follistatin, an activin-binding protein, in the inhibition of activin action in rat pituitary cells. Endocytotic degradation of activin and its acceleration by follistatin associated with cell-surface heparan sulfate. J Biol Chem. 1997;272:13835–13842.
   PubMed Web of Science ®Google Scholar
• Suzuki HI. MicroRNA control of TGF-beta signaling. Int J Mol Sci. 2018;19.
   Web of Science ®Google Scholar
• Bosse Y, Rola-Pleszczynski M. Controversy surrounding the increased expression of TGF beta 1 in asthma. Respir Res. 2007;8:66.
   PubMed Web of Science ®Google Scholar
• Kariyawasam HH, Barkans J, Aizen M, et al. Airway submucosal cells expressing TGF-β 1 are significantly increased at a time point when airway remodelling is maximal post-allergen. Am J Respir Crit Care Med. 2009;179:A1397.
   Web of Science ®Google Scholar
• Semitekolou M, Alissafi T, Aggelakopoulou M, et al. Activin-A induces regulatory T cells that suppress T helper cell immune responses and protect from allergic airway disease. J Exp Med. 2009;206:1769–1785.
   PubMed Web of Science ®Google Scholar
• Samitas K, Poulos N, Semitekolou M, et al. Activin-A is overexpressed in severe asthma and is implicated in angiogenic processes. Eur Respir J. 2016;47:769–782.
   PubMed Web of Science ®Google Scholar
• Hardy CL, Lemasurier JS, Olsson F, et al. Interleukin-13 regulates secretion of the tumor growth factor-{beta} superfamily cytokine activin A in allergic airway inflammation. Am J Respir Cell Mol Biol. 2010;42:667–675.
   PubMed Web of Science ®Google Scholar
• Kariyawasam HH, Pegorier S, Barkans J, et al. Activin and transforming growth factor-beta signaling pathways are activated after allergen challenge in mild asthma. J Allergy Clin Immunol. 2009;124:454–462.
   PubMed Web of Science ®Google Scholar
• Karagiannidis C, Hense G, Martin C, et al. Activin A is an acute allergen-responsive cytokine and provides a link to TGF-beta-mediated airway remodeling in asthma. J Allergy Clin Immunol. 2006;117:111–118.
   PubMed Web of Science ®Google Scholar
• Kariyawasam HH, Xanthou G, Barkans J, et al. Basal expression of bone morphogenetic protein receptor is reduced in mild asthma. Am J Respir Crit Care Med. 2008;177:1074–1081.
   PubMed Web of Science ®Google Scholar
• Phipps S, Benyahia F, Ou TT, et al. Acute allergen-induced airway remodeling in atopic asthma. Am J Respir Cell Mol Biol. 2004;31:626–632.
   PubMed Web of Science ®Google Scholar
• Nakao A, Sagara H, Setoguchi Y, et al. Expression of Smad7 in bronchial epithelial cells is inversely correlated to basement membrane thickness and airway hyperresponsiveness in patients with asthma. J Allergy Clin Immunol. 2002;110:873–878.
   PubMed Web of Science ®Google Scholar
• Phipps S, Ying S, Wangoo A, et al. The relationship between allergen-induced tissue eosinophilia and markers of repair and remodeling in human atopic skin. J Immunol. 2002;169:4604–4612.
   PubMed Web of Science ®Google Scholar
• Flood-Page P, Menzies-Gow A, Phipps S, et al. Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmatics. J Clin Invest. 2003;112:1029–1036.
   PubMed Web of Science ®Google Scholar
• Kariyawasam HH, Robinson DS. The role of eosinophils in airway tissue remodelling in asthma. Curr Opin Immunol. 2007;19:681–686.
   PubMed Web of Science ®Google Scholar
• Ohno I, Nitta Y, Yamauchi K, et al. Transforming growth factor beta 1 (TGF beta 1) gene expression by eosinophils in asthmatic airway inflammation. Am J Respir Cell Mol Biol. 1996;15:404–409.
   PubMed Web of Science ®Google Scholar
• Cho JY, Miller M, Baek KJ, et al. Inhibition of airway remodeling in IL-5-deficient mice. J Clin Invest. 2004;113:551–560.
   PubMed Web of Science ®Google Scholar
• Humbles AA, Lloyd CM, McMillan SJ, et al. A critical role for eosinophils in allergic airways remodeling. Science. 2004;305:1776–1779.
   PubMed Web of Science ®Google Scholar
• Sugimoto MA, Vago JP, Perretti M, et al. Mediators of the resolution of the inflammatory response. Trends Immunol. 2019;40:212–227.
   PubMed Web of Science ®Google Scholar
• Letterio JJ, Geiser AG, Kulkarni AB, et al. Autoimmunity associated with TGF-beta1-deficiency in mice is dependent on MHC class II antigen expression. J Clin Invest. 1996;98:2109–2119.
   PubMed Web of Science ®Google Scholar
• McCartney-Francis NL, Mizel DE, Redman RS, et al. Autoimmune Sjogren’s-like lesions in salivary glands of TGF-beta1-deficient mice are inhibited by adhesion-blocking peptides. J Immunol. 1996;157:1306–1312.
   PubMed Web of Science ®Google Scholar
• Wahl SM, Hunt DA, Wakefield LM, et al. Transforming growth factor type beta induces monocyte chemotaxis and growth factor production. Proc Natl Acad Sci U S A. 1987;84:5788–5792.
   PubMed Web of Science ®Google Scholar
• Adams DH, Hathaway M, Shaw J, et al. Transforming growth factor-beta induces human T lymphocyte migration in vitro. J Immunol. 1991;147:609–612.
   PubMed Web of Science ®Google Scholar
• Gruber BL, Marchese MJ, Kew RR. Transforming growth factor-beta 1 mediates mast cell chemotaxis. J Immunol. 1994;152:5860–5867.
   PubMed Web of Science ®Google Scholar
• Postlethwaite AE, Seyer JM. Identification of a chemotactic epitope in human transforming growth factor-beta 1 spanning amino acid residues 368-374. J Cell Physiol. 1995;164:587–592.
   PubMed Web of Science ®Google Scholar
• Allen JB, Manthey CL, Hand AR, et al. Rapid onset synovial inflammation and hyperplasia induced by transforming growth factor beta. J Exp Med. 1990;171:231–247.
   PubMed Web of Science ®Google Scholar
• Luttmann W, Franz P, Matthys H, et al. Effects of TGF-beta on eosinophil chemotaxis. Scand J Immunol. 1998;47:127–130.
   PubMed Web of Science ®Google Scholar
• Wahl SM, Allen JB, Weeks BS, et al. Transforming growth factor beta enhances integrin expression and type IV collagenase secretion in human monocytes. Proc Natl Acad Sci U S A. 1993;90:4577–4581.
   PubMed Web of Science ®Google Scholar
• McCartney-Francis NL, Wahl SM. Transforming growth factor beta: a matter of life and death. J Leukoc Biol. 1994;55:401–409.
   PubMed Web of Science ®Google Scholar
• Cerwenka A, Bevec D, Majdic O, et al. TGF-beta 1 is a potent inducer of human effector T cells. J Immunol. 1994;153:4367–4377.
   PubMed Web of Science ®Google Scholar
• Cerwenka A, Kovar H, Majdic O, et al. Fas- and activation-induced apoptosis are reduced in human T cells preactivated in the presence of TGF-beta 1. J Immunol. 1996;156:459–464.
   PubMed Web of Science ®Google Scholar
• Strobl H, Knapp W. TGF-beta1 regulation of dendritic cells. Microbes Infect. 1999;1:1283–1290.
   PubMed Web of Science ®Google Scholar
• Foucras G, Coudert JD, Coureau C, et al. Dendritic cells prime in vivo alloreactive CD4 T lymphocytes toward type 2 cytokine- and TGF-beta-producing cells in the absence of CD8 T cell activation. J Immunol. 2000;165:4994–5003.
   PubMed Web of Science ®Google Scholar
• Van Weyenbergh J, PS MP, Bafica A, et al. IFN-beta and TGF-beta differentially regulate IL-12 activity in human peripheral blood mononuclear cells. Immunol Lett. 2001;75:117–122.
   PubMed Web of Science ®Google Scholar
• Balazovich KJ, Fernandez R, Hinkovska-Galcheva V, et al. Transforming growth factor-beta1 stimulates degranulation and oxidant release by adherent human neutrophils. J Leukoc Biol. 1996;60:772–777.
   PubMed Web of Science ®Google Scholar
• Wahl SM, Allen JB, Welch GR, et al. Transforming growth factor-beta in synovial fluids modulates Fc gamma RII (CD16) expression on mononuclear phagocytes. J Immunol. 1992;148:485–490.
   PubMed Web of Science ®Google Scholar
• Rose DM, Fadok VA, Riches DW, et al. Autocrine/paracrine involvement of platelet-activating factor and transforming growth factor-beta in the induction of phosphatidylserine recognition by murine macrophages. J Immunol. 1995;155:5819–5825.
   PubMed Web of Science ®Google Scholar
• Welch GR, Wong HL, Wahl SM. Selective induction of Fc gamma RIII on human monocytes by transforming growth factor-beta. J Immunol. 1990;144:3444–3448.
   PubMed Web of Science ®Google Scholar
• Fadok VA, Bratton DL, Konowal A, et al. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J Clin Invest. 1998;101:890–898.
   PubMed Web of Science ®Google Scholar
• Woolley KL, Gibson PG, Carty K, et al. Eosinophil apoptosis and the resolution of airway inflammation in asthma. Am J Respir Crit Care Med. 1996;154:237–243.
   PubMed Web of Science ®Google Scholar
• Alam R, Forsythe P, Stafford S, et al. Transforming growth factor beta abrogates the effects of hematopoietins on eosinophils and induces their apoptosis. J Exp Med. 1994;179:1041–1045.
   PubMed Web of Science ®Google Scholar
• Yamaguchi Y, Suda T, Ohta S, et al. Analysis of the survival of mature human eosinophils: interleukin-5 prevents apoptosis in mature human eosinophils. Blood. 1991;78:2542–2547.
   PubMed Web of Science ®Google Scholar
• Oswald IP, Gazzinelli RT, Sher A, et al. IL-10 synergizes with IL-4 and transforming growth factor-beta to inhibit macrophage cytotoxic activity. J Immunol. 1992;148:3578–3582.
   PubMed Web of Science ®Google Scholar
• Tsunawaki S, Sporn M, Ding A, et al. Deactivation of macrophages by transforming growth factor-beta. Nature. 1988;334:260–262.
   PubMed Web of Science ®Google Scholar
• Nelson BJ, Ralph P, Green SJ, et al. Differential susceptibility of activated macrophage cytotoxic effector reactions to the suppressive effects of transforming growth factor-beta 1. J Immunol. 1991;146:1849–1857.
   PubMed Web of Science ®Google Scholar
• Sillett HK, Cruickshank SM, Southgate J, et al. Transforming growth factor-beta promotes ‘death by neglect’ in post-activated human T cells. Immunology. 2001;102:310–316.
   PubMed Web of Science ®Google Scholar
• Kariyawasam HH, Robinson DS. Airway remodelling in asthma: models and supermodels? Clin Exp Allergy. 2005;35:117–121.
   PubMed Web of Science ®Google Scholar
• Zhang S, Smartt H, Holgate ST, et al. Growth factors secreted by bronchial epithelial cells control myofibroblast proliferation: an in vitro co-culture model of airway remodeling in asthma. Lab Invest. 1999;79:395–405.
   PubMed Web of Science ®Google Scholar
• Fjellbirkeland L, Cambier S, Broaddus VC, et al. Integrin alphavbeta8-mediated activation of transforming growth factor-beta inhibits human airway epithelial proliferation in intact bronchial tissue. Am J Pathol. 2003;163:533–542.
   PubMed Web of Science ®Google Scholar
• Reddy KB, Hocevar BA, Howe PH. Inhibition of G1 phase cyclin dependent kinases by transforming growth factor beta 1. J Cell Biochem. 1994;56:418–425.
   PubMed Web of Science ®Google Scholar
• Puddicombe SM, Torres-Lozano C, Richter A, et al. Increased expression of p21(waf) cyclin-dependent kinase inhibitor in asthmatic bronchial epithelium. Am J Respir Cell Mol Biol. 2003;28:61–68.
   PubMed Web of Science ®Google Scholar
• Vignola AM, Chanez P, Chiappara G, et al. Transforming growth factor-beta expression in mucosal biopsies in asthma and chronic bronchitis. Am J Respir Crit Care Med. 1997;156:591–599.
   PubMed Web of Science ®Google Scholar
• McAnulty RJ, Hernandez-Rodriguez NA, Mutsaers SE, et al. Indomethacin suppresses the anti-proliferative effects of transforming growth factor-beta isoforms on fibroblast cell cultures. Biochem J. 1997;321(Pt 3):639–643.
   PubMedGoogle Scholar
• Thannickal VJ, Lee DY, White ES, et al. Myofibroblast differentiation by transforming growth factor-beta1 is dependent on cell adhesion and integrin signaling via focal adhesion kinase. J Biol Chem. 2003;278:12384–12389.
   PubMed Web of Science ®Google Scholar
• Coker RK, Laurent GJ, Shahzeidi S, et al. Transforming growth factors-beta 1, -beta 2, and -beta 3 stimulate fibroblast procollagen production in vitro but are differentially expressed during bleomycin-induced lung fibrosis. Am J Pathol. 1997;150:981–991.
   PubMed Web of Science ®Google Scholar
• Ignotz RA, Endo T, Massague J. Regulation of fibronectin and type I collagen mRNA levels by transforming growth factor-beta. J Biol Chem. 1987;262:6443–6446.
   PubMed Web of Science ®Google Scholar
• McAnulty RJ, Chambers RC, Laurent GJ. Regulation of fibroblast procollagen production. Transforming growth factor-beta 1 induces prostaglandin E2 but not procollagen synthesis via a pertussis toxin-sensitive G-protein. Biochem J. 1995;307(Pt 1):63–68.
   PubMedGoogle Scholar
• Romaris M, Heredia A, Molist A, et al. Differential effect of transforming growth factor beta on proteoglycan synthesis in human embryonic lung fibroblasts. Biochim Biophys Acta. 1991;1093:229–233.
   PubMedGoogle Scholar
• Westergren-Thorsson G, Antonsson P, Malmstrom A, et al. The synthesis of a family of structurally related proteoglycans in fibroblasts is differently regulated by TFG-beta. Matrix. 1991;11:177–183.
   PubMedGoogle Scholar
• Zeng G, McCue HM, Mastrangelo L, et al. Endogenous TGF-beta activity is modified during cellular aging: effects on metalloproteinase and TIMP-1 expression. Exp Cell Res. 1996;228:271–276.
   PubMed Web of Science ®Google Scholar
• Lund LR, Riccio A, Andreasen PA, et al. Transforming growth factor-beta is a strong and fast acting positive regulator of the level of type-1 plasminogen activator inhibitor mRNA in WI-38 human lung fibroblasts. Embo J. 1987;6:1281–1286.
   PubMed Web of Science ®Google Scholar
• Cohen MD, Ciocca V, Panettieri RA Jr. TGF-beta 1 modulates human airway smooth-muscle cell proliferation induced by mitogens. Am J Respir Cell Mol Biol. 1997;16:85–90.
   PubMed Web of Science ®Google Scholar
• Coutts A, Chen G, Stephens N, et al. Release of biologically active TGF-beta from airway smooth muscle cells induces autocrine synthesis of collagen. Am J Physiol Lung Cell Mol Physiol. 2001;280:L999–1008.
   PubMed Web of Science ®Google Scholar
• Funaba M, Ikeda T, Ogawa K, et al. Role of activin A in murine mast cells: modulation of cell growth, differentiation, and migration. J Leukoc Biol. 2003;73:793–801.
   PubMed Web of Science ®Google Scholar
• Ogawa K, Funaba M, Tsujimoto M. A dual role of activin A in regulating immunoglobulin production of B cells. J Leukoc Biol. 2008;83:1451–1458.
   PubMed Web of Science ®Google Scholar
• Robson NC, Phillips DJ, McAlpine T, et al. Activin-A: a novel dendritic cell-derived cytokine that potently attenuates CD40 ligand-specific cytokine and chemokine production. Blood. 2008;111:2733–2743.
   PubMed Web of Science ®Google Scholar
• Brosh N, Sternberg D, Honigwachs-Sha’anani J, et al. The plasmacytoma growth inhibitor restrictin-P is an antagonist of interleukin 6 and interleukin 11. Identification as a stroma-derived activin A. J Biol Chem. 1995;270:29594–29600.
   PubMed Web of Science ®Google Scholar
• Huber S, Stahl FR, Schrader J, et al. Activin a promotes the TGF-beta-induced conversion of CD4+. J Immunol. 2009;182:4633–4640.
   PubMed Web of Science ®Google Scholar
• Semitekolou M, Morianos I, Banos A, et al. Dendritic cells conditioned by activin A-induced regulatory T cells exhibit enhanced tolerogenic properties and protect against experimental asthma. J Allergy Clin Immunol. 2018;141:671–684.e677.
   PubMed Web of Science ®Google Scholar
• Ohga E, Matsuse T, Teramoto S, et al. Effects of activin A on proliferation and differentiation of human lung fibroblasts. Biochem Biophys Res Commun. 1996;228:391–396.
   PubMed Web of Science ®Google Scholar
• Cho SH, Yao Z, Wang SW, et al. Regulation of activin A expression in mast cells and asthma: its effect on the proliferation of human airway smooth muscle cells. J Immunol. 2003;170:4045–4052.
   PubMed Web of Science ®Google Scholar
• Matsuse T, Fukuchi Y, Eto Y, et al. Expression of immunoreactive and bioactive activin A protein in adult murine lung after bleomycin treatment. Am J Respir Cell Mol Biol. 1995;13:17–24.
   PubMed Web of Science ®Google Scholar
• Gregory LG, Mathie SA, Walker SA, et al. Overexpression of Smad2 drives house dust mite-mediated airway remodeling and airway hyperresponsiveness via activin and IL-25. Am J Respir Crit Care Med. 2010;182:143–154.
   PubMed Web of Science ®Google Scholar
• Zeisberg M, Hanai J, Sugimoto H, et al. BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury. Nat Med. 2003;9:964–968.
   PubMed Web of Science ®Google Scholar
• Zeisberg M, Bottiglio C, Kumar N, et al. Bone morphogenic protein-7 inhibits progression of chronic renal fibrosis associated with two genetic mouse models. Am J Physiol Renal Physiol. 2003;285:F1060–1067.
   PubMed Web of Science ®Google Scholar
• Izumi N, Mizuguchi S, Inagaki Y, et al. BMP-7 opposes TGF-beta1-mediated collagen induction in mouse pulmonary myofibroblasts through Id2. Am J Physiol Lung Cell Mol Physiol. 2006;290:L120–126.
   PubMed Web of Science ®Google Scholar
• Gould SE, Day M, Jones SS, et al. BMP-7 regulates chemokine, cytokine, and hemodynamic gene expression in proximal tubule cells. Kidney Int. 2002;61:51–60.
   PubMed Web of Science ®Google Scholar
• Maric I, Poljak L, Zoricic S, et al. Bone morphogenetic protein-7 reduces the severity of colon tissue damage and accelerates the healing of inflammatory bowel disease in rats. J Cell Physiol. 2003;196:258–264.
   PubMed Web of Science ®Google Scholar
• Stumm CL, Halcsik E, Landgraf RG, et al. Lung remodeling in a mouse model of asthma involves a balance between TGF-beta1 and BMP-7. PLoS One. 2014;9:e95959.
   PubMed Web of Science ®Google Scholar
• Huse K, Bakkebo M, Oksvold MP, et al. Bone morphogenetic proteins inhibit CD40L/IL-21-induced Ig production in human B cells: differential effects of BMP-6 and BMP-7. Eur J Immunol. 2011;41:3135–3145.
   PubMed Web of Science ®Google Scholar
• Pegorier S, Campbell GA, Kay AB, et al. Bone morphogenetic protein (BMP)-4 and BMP-7 regulate differentially transforming growth factor (TGF)-beta1 in normal human lung fibroblasts (NHLF). Respir Res. 2010;11:85.
   PubMed Web of Science ®Google Scholar
• Murray LA, Hackett TL, Warner SM, et al. BMP-7 does not protect against bleomycin-induced lung or skin fibrosis. PLoS One. 2008;3:e4039.
   PubMed Web of Science ®Google Scholar
• Balzar S, Chu HW, Silkoff P, et al. Increased TGF-beta2 in severe asthma with eosinophilia. J Allergy Clin Immunol. 2005;115:110–117.
   PubMed Web of Science ®Google Scholar
• Khalil N, Parekh TV, O’Connor RN, et al. Differential expression of transforming growth factor-beta type I and II receptors by pulmonary cells in bleomycin-induced lung injury: correlation with repair and fibrosis. Exp Lung Res. 2002;28:233–250.
   PubMed Web of Science ®Google Scholar
• Brandes ME, Wakefield LM, Wahl SM. Modulation of monocyte type I transforming growth factor-beta receptors by inflammatory stimuli. J Biol Chem. 1991;266:19697–19703.
   PubMed Web of Science ®Google Scholar
• Goumans MJ, Lebrin F, Valdimarsdottir G. Controlling the angiogenic switch: a balance between two distinct TGF-b receptor signaling pathways. Trends Cardiovasc Med. 2003;13:301–307.
   PubMed Web of Science ®Google Scholar
• Scharpfenecker M, van Dinther M, Liu Z, et al. BMP-9 signals via ALK1 and inhibits bFGF-induced endothelial cell proliferation and VEGF-stimulated angiogenesis. J Cell Sci. 2007;120:964–972.
   PubMed Web of Science ®Google Scholar
• Aoki F, Kurabayashi M, Hasegawa Y, et al. Attenuation of bleomycin-induced pulmonary fibrosis by follistatin. Am J Respir Crit Care Med. 2005;172:713–720.
   PubMed Web of Science ®Google Scholar
• Gregory LG, Jones CP, Walker SA, et al. IL-25 drives remodelling in allergic airways disease induced by house dust mite. Thorax. 2013;68:82–90.
   PubMed Web of Science ®Google Scholar
• Lynn TM, Molloy EL, Masterson JC, et al. SMAD signaling in the airways of healthy rhesus macaques versus rhesus macaques with asthma highlights a relationship between inflammation and bone morphogenetic proteins. Am J Respir Cell Mol Biol. 2016;54:562–573.
   PubMed Web of Science ®Google Scholar
• Fokkens WJ, Lund VJ, Mullol J, et al. European position paper on rhinosinusitis and nasal polyps 2012. Rhinol Suppl. 2012;23:3 1–298.
   PubMedGoogle Scholar
• Kariyawasam HH, Rotiroti G. Allergic rhinitis, chronic rhinosinusitis and asthma: unravelling a complex relationship. Curr Opin Otolaryngol Head Neck Surg. 2013;21:79–86.
   PubMed Web of Science ®Google Scholar
• Van BN, Derycke L, Perez-Novo CA, et al. TGF-beta signaling and collagen deposition in chronic rhinosinusitis. J Allergy Clin Immunol. 2009;124(253–259):259.
   Google Scholar
• Yamin M, Holbrook EH, Gray ST, et al. Profibrotic transforming growth factor beta 1 and activin A are increased in nasal polyp tissue and induced in nasal polyp epithelium by cigarette smoke and toll-like receptor 3 ligation. Int Forum Allergy Rhinol. 2015;5:573–582.
   PubMed Web of Science ®Google Scholar
• Yang Y, Zhang N, Crombruggen KV, et al. Differential expression and release of Activin A and follistatin in chronic rhinosinusitis with and without nasal polyps. PLoS One. 2015;10:e0128564.
   PubMed Web of Science ®Google Scholar
• Chaker AM, Zissler UM, Poulos N, et al. Activin-A is a pro-inflammatory regulator in type-2-driven upper airway disease. Int Arch Allergy Immunol. 2018;176:15–25.
   PubMed Web of Science ®Google Scholar
• Tengroth L, Arebro J, Larsson O, et al. Activation of activin receptor-like kinases curbs mucosal inflammation and proliferation in chronic rhinosinusitis with nasal polyps. Sci Rep. 2018;8:1561.
   PubMed Web of Science ®Google Scholar
• Wu J, Ding Y, Wang J, et al. Staphylococcus aureus induces TGF-beta1 and bFGF expression through the activation of AP-1 and NF-kappaB transcription factors in bovine mammary epithelial cells. Microb Pathog. 2018;117:276–284.
   PubMed Web of Science ®Google Scholar
• Jones KL, Mansell A, Patella S, et al. Activin A is a critical component of the inflammatory response, and its binding protein, follistatin, reduces mortality in endotoxemia. Proc Natl Acad Sci U S A. 2007;104:16239–16244.
   PubMed Web of Science ®Google Scholar
• Nicholson GC, Kariyawasam HH, Tan AJ, et al. The effects of an anti-IL-13 mAb on cytokine levels and nasal symptoms following nasal allergen challenge. J Allergy Clin Immunol. 2011;128:800–807.
   PubMed Web of Science ®Google Scholar
• Kariyawasam HH, Aizen M, Kay AB, et al. Safety and tolerability of three consecutive bronchoscopies after allergen challenge in volunteers with mild asthma. Thorax. 2007;62:557–558.
   PubMed Web of Science ®Google Scholar